[Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects]

Dtsch Med Wochenschr. 2003 Feb 21;128(8):378-85. doi: 10.1055/s-2003-37378.

[Article in German]

Authors

M Schwab¹, K Herrlinger, E Schaeffeler, E F Stange

Affiliation

¹ Dr. Margarete Fischer-Bosch Institut für Klinische Pharmakologie, Stuttgart.

PMID: 12594624
DOI: 10.1055/s-2003-37378

No abstract available

Publication types

Review

MeSH terms

Azathioprine / adverse effects
Azathioprine / chemistry
Azathioprine / therapeutic use*
Bone Marrow / drug effects
Drug Interactions
Drug Monitoring
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / chemistry
Immunosuppressive Agents / therapeutic use*
Inflammatory Bowel Diseases / drug therapy*
Lymphoma, Non-Hodgkin / chemically induced
Mercaptopurine / adverse effects
Mercaptopurine / chemistry
Mercaptopurine / therapeutic use*
Methyltransferases / blood
Methyltransferases / genetics
Methyltransferases / metabolism
Structure-Activity Relationship
Thioguanine / adverse effects
Thioguanine / chemistry
Thioguanine / therapeutic use*

Substances

Immunosuppressive Agents
Mercaptopurine
Methyltransferases
thiopurine methyltransferase
Thioguanine
Azathioprine